This week Nick Burr and Bjorn Rembacken are discussing the bright new world of molecular screening for occult cancers as the NHS starts screening for more than 50 cancers. This summer the “Galleri blood test”, developed by an American company called ‘GRAIL’ will be piloted on 140.000 healthy people in the UK.
Naturally, Bjorn remains sceptical, and after an unsuccessful search for the ‘study aims’, asks if getting a positive result always mean that the cancer is treatable? Furthermore, how do you tell the difference between a true positive and a false positive?
Surprisingly, we are also standing up for the effectiveness of CTC and wonder why an American study reports such shockingly poor results.
Implications of the New Monitoring Guidelines in Endoscopy
Green Endoscopy - Time to ’Look UP’!
Bjorn gives an overview on the Endoscopic highlights of the UEG Week 2021.
Launch of the Worlds largest audit of PCCRC
What can we do about endoscope contamination? An interview with Marco Bruno
Our Endoscopy News Review of the latest articles worth knowing about!
EoE, ERAT, BLI, NF-NBI and MSH6
Bjorn's Endoscopy News Review - April 2021
You need to know this to reduce the risk of missing anal cancer ...
Neil Shepherd on serrated polyps and much much more!
Should we be more proactive in dealing with colonic lipomas and local recurrence after oesophageal CRT?
BSG Campus 2021
The pitfalls and problems which trips you up managing Gastric NET's
Can we predict the risk of cancer in colitis?
Leeds Endoscopy Christmas Quiz 2020
Promises and Pitfalls of sending your patient for an EUS-BD
The UK 'National Endoscopy Database' - the most ambitious in the World !
News on the aetiology of achalasia and Sheffield changes its mind on Coeliac !
Our obsession with ADR and PCCRC
Create your
podcast in
minutes
It is Free
The Relaxback UK Show
Good Nurse Bad Nurse
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive